Weekly injection trial aims to halt debilitating heart disease
NCT ID NCT03702829
Summary
This study tested whether weekly injections of a drug called inotersen could slow or stop the progression of a serious heart condition called TTR amyloid cardiomyopathy. The drug works by reducing the production of a problematic protein that builds up and damages the heart. Over 24 months, researchers monitored 31 patients with this condition to see if the treatment was safe and if it helped preserve heart function compared to what typically happens without it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.